ICSI (Intracytoplasmic Sperm Injection) Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Dnali1 is required for sperm motility and male fertility in mice
ConclusionsOur results uncover a role of DNALI1 in sperm motility and male fertility in mice, and demonstrate that ICSI overcomesDnali1-associated male infertility, thus providing guidance for the diagnosis and genetic counseling ofDNALI1-associated human infertility. (Source: Basic and Clinical Andrology)
Source: Basic and Clinical Andrology - November 23, 2023 Category: Urology & Nephrology Source Type: research

Analysis of risk factors for recurrence in infertile endometrial cancer patients after in vitro fertilization treatment
ConclusionsLive birth was associated with decreased recurrence of EEC. Reducing estrogen levels during COS may serve to mitigate the risk of endometrial cancer recurrence. (Source: Frontiers in Endocrinology)
Source: Frontiers in Endocrinology - November 22, 2023 Category: Endocrinology Source Type: research

Strong social disparities in access to IVF/ICSI despite free cost of treatment: a French population-based nationwide cohort study
Access to IVF/ICSI is facilitated when the financial barrier is removed. In a national context where in vitro fertilisation (IVF)/intracytoplasmic sperm Injection (ICSI) treatment is cost-free, how many women ... (Source: BMC Women's Health)
Source: BMC Women's Health - November 22, 2023 Category: OBGYN Authors: Khaoula Ben Messaoud, Juliette Guibert, Jean Bouyer and Elise de La Rochebrochard Tags: Research Source Type: research

Reply of the authors: Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection
(Source: Fertility and Sterility)
Source: Fertility and Sterility - November 21, 2023 Category: Reproduction Medicine Authors: Craig A. Witz, Kevin J. Doody, John K. Park, Gaurang S. Daftary, Patrick W. Heiser Tags: Letters to the editor Source Type: research

Response to: Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection
We appreciate the new interest in our 2020 publication describing outcomes from MEGASET-HR, a randomized trial of 620 predicted high-responder women undergoing ovarian stimulation with highly purified human menotropin (HP-hMG) or recombinant follicle-stimulating hormone (rFSH) (1). It was a prospective follow-up to post hoc analyses of studies suggesting that patients predicted to be high responders benefit from treatment with HP-hMG (2). We disagree with the opinions expressed by Batista et al. (Source: Fertility and Sterility)
Source: Fertility and Sterility - November 21, 2023 Category: Reproduction Medicine Authors: Craig A. Witz, Kevin J. Doody, John K. Park, Gaurang S. Daftary, Patrick W. Heiser Tags: Letter to the editor Source Type: research